Diamyd Medical’s phase 3 diabetes trial passes final safety review
Investing.com - Curiositystream (NASDAQ: CURI) reported third quarter EPS of $-0.060, $0.03 worse than the analyst estimate of $-0.030. Revenue for the quarter came in at $18.4M versus the consensus estimate of $16.19M.
Guidance
Curiositystream sees Q4 2025 revenue of $18.000M-$20.000M versus the analyst consensus of $18.070M.
Curiositystream’s stock price closed at $3.75. It is down -6.950% in the last 3 months and up 146.710% in the last 12 months.
Curiositystream saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Curiositystream’s stock price’s past reactions to earnings here.
According to InvestingPro, Curiositystream’s Financial Health score is "fair performance".
Check out Curiositystream’s recent earnings performance, and Curiositystream’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
